News | News By Subject | News by Disease News By Date | Search News

Alzheimer's Disease News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Fear of Layoffs Loom Over Eli Lilly (LLY) Employees After Alzheimer's Setback     12/1/2016
Devastation Hits as Eli Lilly (LLY)'s Alzheimer's Drug Flunks Late-Stage Study, Shares Tank     11/29/2016
Investors Remain Bullish Over Biogen (BIIB)'s Risky Alzheimer's Drug Despite Eli Lilly (LLY) Setback     11/28/2016
Former Allergan (AGN) Exec Who Now Helms Chase Pharma Inks $1 Billion Pact With Brent Saunders and His New Gang     11/28/2016
5 Drug Giants That Could Dominate the $13 Billion Alzheimer's Market     11/23/2016
As Eli Lilly (LLY)'s ALZ Data Looms, Here Are Some Things Investors Need to Know     11/18/2016
Investors Hold Their Breath for the "Most Important Event in Biotech"—Here are 5 Stocks to Watch     11/18/2016
3 Reasons That Make Biogen (BIIB) the King of a Crumbling Empire     11/14/2016
Merck & Co. (MRK)'s Alzheimer's Contender Wows in Human Clinical Trial     11/3/2016
Why Biogen (BIIB)'s Fate May Depend on Eli Lilly (LLY)'s Alzheimer's Data     10/27/2016
How Pfizer (PFE) is Quietly Rebuilding Its Alzheimer's Pipeline     10/19/2016
All Eyes on Eli Lilly (LLY)'s Large-Scale Alzheimer's Trial     10/17/2016
A Look at This Tiny Massachusetts Biotech That Could Take Down Alzheimer's     10/11/2016
H. Lundbeck A/S (LUN.CO)'s Phase III Data Crushes Hope for Alzheimer’s Once Again     9/23/2016
Will Biogen (BIIB)’s Alzheimer’s Drug Be a Miracle Drug or Just Another Bomb?     9/20/2016

News from Around the Web
Catalyst Driver For PDL BioPharma (PDLI) Is Coming     11/18/2016
Alzheimer’s Didn’t Cause Memory Loss For These Superaging 90-Year Olds, Northwestern University Feinberg School of Medicine Study     11/17/2016
Eli Lilly (LLY)'s Solanezumab And The History Of The Future Of Treating Alzheimer's Disease     11/11/2016
Baylor College of Medicine Take First Steps Toward A Preventative Alzheimer's Pill     10/25/2016
University of Pennsylvania Psychiatrist Questions Whether Antidepressants Prevent Alzheimer's     10/10/2016
Genetic Score Predicts Age-Related Risk Of Alzheimer's Disease, University of California, San Diego (UCSD) Study Says     10/5/2016
Eli Lilly (LLY)'s Alzheimer's Drug Could Potentially Bring in Billions     9/28/2016
Getting Real About An Alzheimer's Cure     9/9/2016
Lancaster University Scientists Link Air Pollution To Alzheimer's     9/6/2016
Shark Fins And Meat Contain High Levels Of Neurotoxins Linked To Alzheimer's, University of Miami Study Reveals     8/30/2016
Use It Or Lose It: Stopping Exercise Decreases Brain Blood Flow, University of Maryland Study Shows     8/30/2016
Gene Wilder Died Of Alzheimer’s. His Family Explains Why They Didn’t Disclose His Diagnosis     8/30/2016
This Helmet Shows What's Going On Inside A Person's Brain, Department of Energy Study     8/23/2016
Diet And Exercise Could Stop Alzheimer's From Forming, UCLA Study     8/17/2016
Treatment Option For Alzheimer’s Disease Possible, University of Manchester Study     8/15/2016

Press Releases
Alzheimer's Foundation Awards Feinstein Institute Grant To Study Aggression In Alzheimer's Disease     12/2/2016
Neuronix Ltd. Reports Positive Results In Its Multi-Center Alzheimer's Study And Submits Its Therapy System For FDA Clearance     11/29/2016
Eli Lilly (LLY) Alzheimer’s Drug Fails To Show Benefits In Final Stage Clinical Trial     11/28/2016
Cognition Therapeutics Sees Eli Lilly (LLY) Solanezumab Clinical Trial Results As Support For Its Unique Mechanism For Treatment Of Alzheimer's Disease     11/28/2016
Nature Cell Receives U.S. FDA Approval For Phase I And II Alzheimer's Clinical Trial     11/28/2016
Neurotrope Issues Statement On Eli Lilly (LLY)'s Solanezumab     11/23/2016
Aurin Biotech’s Simple Saliva Test Predicts Future Onset Of Alzheimer’s Disease     11/21/2016
Proclara Awarded Part The Cloud Grant From Alzheimer’s Association To Support Development Of NPT088 For Alzheimer’s Disease     11/18/2016
FDA Grants Fast Track Designation For Development Of E2609, Eisai Inc. (ESALF.PK)'s BACE Inhibitor For Early Alzheimer's Disease     11/17/2016
Probiodrug AG Release: Amyloid-beta (Abeta) Aggregate-Clearing By The Murine Anti-Pyroglutamate-3 Abeta IgG2a Monoclonal Antibody PBD-C06 With And Without A Complement Mutation In An Alzheimer’s Mouse Model     11/16/2016
Cognition Therapeutics Announces Dosing Of First Alzheimer's Patient In Phase 1b Trial Of CT1812     11/14/2016
ProMis Neurosciences Initiates Groundbreaking Cohort Study To Evaluate Prevalence Of Different Amyloid Beta Prion Strains In Alzheimer's Disease     11/9/2016
Worldwide Clinical Trials To Present Webinar On Improving Screen Failure And Recruitment Rates In Alzheimer's Disease Trials     11/4/2016
ProMis Neurosciences Announces Five Novel Antibody Products Meeting Ideal Target Profile For Alzheimer's Disease     11/3/2016
University of California, Irvine Doses First Patient In Phase IIa Clinical Trial Using Stemedica's Stem Cells For Alzheimer's Disease     11/1/2016

//-->